Sana Biotechnology
SANA----
Sana Biotechnology (SANA)
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Sana Biotechnology Analyst Rating
View MoreForecast & Rating
Jun 26, 2026Price forecast
$8.57158.96%
Forecast & RatingStrong buy
9analysts
- Strong buy66.67%
- Buy22.22%
- Hold11.11%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 13 at 07:07 AM
Sana Biotechnology plans IND filing, targets Phase 1/2 start this year for SC451 type 1 diabetes therapy
- Simplywall · Jul 8 at 02:57 PM
Sana Biotechnology (SANA) Is Up 18.1% After Removal From Key Russell Value Indexes - What's Changed
- PUBT · Jul 1 at 08:03 AM
Sana Biotechnology to present first-in-human hypoimmune islet transplant data at EASD 2026
- Simplywall · Jul 1 at 03:05 AM
Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative?
- TradingView · Jun 11 at 11:20 PM
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside
- PR Newswire · Jun 2 at 05:11 PM
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
